EGFR and glioblastoma: For example, Pyruvate kinase M2 (PKM2) translocates into the nucleus in epidermal growth factor receptor (EGFR) activated glioblastoma cells, where it associates with β-Catenin to facilitate its recruitment to the CCND1 promoter, leading to tumor cell proliferation and brain tumor development17.